Grant: Collaborative Health Research Projects
University of Toronto
$62,052.00
Development of a sensitive noninvasive biothermophotonic device for blood glucose monitoring in diabetic patients
EF 2009-10
Résumé
Diabetes mellitus afflicts a large and growing number of people worldwide - over 2 million in Canada alone costing the health care system over $13.2 billion/year. To manage this condition, and to reduce the risk of severe long term health complications, patients check blood sugar levels up to five times a day to maintain physiological glucose concentration between 90 and 120 mg/dl. The standard technique for measurement of glucose concentration requires skin puncture to draw a small blood sample which can be examined using a test strip and automated meter to report results. Although this technique provides accurate glucose concentration data, frequent skin puncture is associated with significant discomfort, pain and risk of infection. Despite significant effort directed towards development of noninvasive and minimally-invasive techniques for glucose monitoring over the past twenty years, no completely noninvasive sensor is available at the moment. The proposed biothermophotonic technique relies on recent advances in infrared (IR) quantum cascade laser and non-cryogenic IR detector developments, the judicious choice of differential absorption in tissue in the 9-10.5 um glucose absorption band and detection of photothermal blackbody emission photons in the mid-IR spectral band away from the absorption region. The differential thermal-wave signal can be related to glucose concentration in the tissue specimen (A. Mandelis and S. Telenkov, US patent pending). This technique may be applied for measurements of glucose concentration in the interstitial fluid of the superficial skin layers to establish correlation with glucose concentration in the blood. Since it measures only a differential signal it stands a chance to become an absolute measure of glucose concentration. We envision the development of a portable, relatively inexpensive instrument with two small low-power out-of-phase-current-modulated quantum cascade laser sources providing wavelength modulation, IR delivery and collection fiber optics or hollow waveguides, signal processing and control unit, and a suitable body-part rest unit for laser beam exposure. The outcome of this research will place Canada on the map of noninvasive glucose biosensor technology.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
351003-2008
Name nom
Mandelis, Andreas
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
62052
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
2
Nb partie
3
Application title
Development of a sensitive noninvasive biothermophotonic device for blood glucose monitoring in diabetic patients
Keyword
NA
Application summary
Diabetes mellitus afflicts a large and growing number of people worldwide - over 2 million in Canada alone costing the health care system over $13.2 billion/year. To manage this condition, and to reduce the risk of severe long term health complications, patients check blood sugar levels up to five times a day to maintain physiological glucose concentration between 90 and 120 mg/dl. The standard technique for measurement of glucose concentration requires skin puncture to draw a small blood sample which can be examined using a test strip and automated meter to report results. Although this technique provides accurate glucose concentration data, frequent skin puncture is associated with significant discomfort, pain and risk of infection. Despite significant effort directed towards development of noninvasive and minimally-invasive techniques for glucose monitoring over the past twenty years, no completely noninvasive sensor is available at the moment. The proposed biothermophotonic technique relies on recent advances in infrared (IR) quantum cascade laser and non-cryogenic IR detector developments, the judicious choice of differential absorption in tissue in the 9-10.5 um glucose absorption band and detection of photothermal blackbody emission photons in the mid-IR spectral band away from the absorption region. The differential thermal-wave signal can be related to glucose concentration in the tissue specimen (A. Mandelis and S. Telenkov, US patent pending). This technique may be applied for measurements of glucose concentration in the interstitial fluid of the superficial skin layers to establish correlation with glucose concentration in the blood. Since it measures only a differential signal it stands a chance to become an absolute measure of glucose concentration. We envision the development of a portable, relatively inexpensive instrument with two small low-power out-of-phase-current-modulated quantum cascade laser sources providing wavelength modulation, IR delivery and collection fiber optics or hollow waveguides, signal processing and control unit, and a suitable body-part rest unit for laser beam exposure. The outcome of this research will place Canada on the map of noninvasive glucose biosensor technology.